Acurx PharmaceuticalsACXP
13F holders, Q4 2024 (December 31)26holders +4
7new positions
4sold out
1famous investor
$0.81avg. 13F price*
At the end of Q4 2024, 26 institutions reported holding Acurx Pharmaceuticals Inc. (ACXP) in their 13F filings, up 4 from Q3 2024. 7 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($431K), Prospect Financial Services LLC ($268K) and Geode Capital Management, LLC ($119K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Acurx Pharmaceuticals Inc.
- CUSIP
- 00510M104
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $121K |
| Exits | 4 | $140K |
All 13F filers, Q3 2024 → Q4 2024: 247,095 shares bought and 78,850 shares sold, net +168,245 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Vanguard Group Inc. | 0.00% | No change | 529,349 | $431K |
| Prospect Financial Services LLC | 0.15% | Add +11.5% | 329,076 | $268K |
| Geode Capital Management, LLC | 0.00% | No change | 146,500 | $119K |
| Morgan Stanley | 0.00% | Add +129.9% | 106,201 | $86K |
| Susquehanna International Group, LLP | 0.00% | New | 48,374 | $39K |
| State Street Corp. | 0.00% | No change | 43,466 | $35K |
| Virtu Financial LLC | 0.00% | New | 27,836 | $23K |
| Northern Trust Corp. | 0.00% | No change | 27,286 | $22K |
| BlackRock, Inc. | 0.00% | Reduce -9.2% | 25,911 | $21K |
| ACT Advisors, LLC. | 0.01% | New | 21,284 | $17K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 18,656 | $15K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 17,750 | $14K |
| Renaissance Technologies | 0.00% | New | 14,674 | $12K |
| Squarepoint Ops LLC | 0.00% | New | 12,537 | $10K |
| Osaic Holdings, Inc. | 0.00% | Reduce -17.5% | 11,725 | $10K |
| Patriot Financial Group Insurance Agency, LLC | 0.00% | No change | 10,385 | $8K |
| Semmax Financial Advisors Inc. | 0.00% | Add +22.1% | 7,179 | $5K |
| UBS Group AG | 0.00% | New | 5,961 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +115.3% | 4,447 | $4K |
| Cornerstone Planning Group LLC | 0.00% | No change | 3,344 | $3K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1,636 | $1K |
| Group One Trading LLC | 0.00% | Add +573.4% | 1,165 | $948 |
| GPS Wealth Strategies Group, LLC | 0.00% | No change | 500 | $407 |
| SBI Securities Co., Ltd. | 0.00% | — | 270 | $220 |
| Bank of America Corp. | 0.00% | Add +3.5% | 117 | $95 |
| Lanark Financial, Inc. | 0.00% | — | 19 | $15 |
"% of holder's portfolio" is ACXP's weight in each manager's 13F, not the share of Acurx Pharmaceuticals Inc. the manager owns.